IGC Pharma, Inc. (IGC) › Total AssetsIGC Pharma, Inc. (IGC) — Total AssetsAnnual figures by fiscal year, from SEC filings.2011: $18.16M2012: $25.26M2013: $19.25M2014: $17.73M2015: $20.33M2016: $18.86M2017: $11.28M2018: $10.85M2019: $34.47M2020: $28.98M2021: $35.87M2022: $26.83M2023: $17.18M2024: $9.90M2025: $9.71M$9.71M2011Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$9.71M-1.9%2024$9.90M-42.4%2023$17.18M-36.0%2022$26.83M-25.2%2021$35.87M+23.7%2020$28.98M-15.9%2019$34.47M+217.6%2018$10.85M-3.8%2017$11.28M-40.2%2016$18.86M-7.2%2015$20.33M+14.6%2014$17.73M-7.9%2013$19.25M-23.8%2012$25.26M+39.1%2011$18.16M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share